Individual risk and prognostic value prediction by machine learning for distant metastasis in pulmonary sarcomatoid carcinoma: a large cohort study based on the SEER database and the Chinese population
Frontiers in Oncology · 26.06.2023 · 13
DOI: 10.3389/fonc.2023.1105224 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Oncology, online erschienen am 26.06.2023. Verfasst von Xinglin Yi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Southwest Hospital of Third Military Medical University, Chongqing, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science-Health Joint Medical Scientific Research Project of Chongqing.
Abstract (Originalsprache)
Background
This study aimed to develop diagnostic and prognostic models for patients with pulmonary sarcomatoid carcinoma (PSC) and distant metastasis (DM).
Methods
Patients from the Surveillance, Epidemiology, and End Results (SEER) database were divided into a training set and internal test set at a ratio of 7 to 3, while those from the Chinese hospital were assigned to the external test set, to develop the diagnostic model for DM. Univariate logistic regression was employed in the training set to screen for DM-related risk factors, which were included into six machine learning (ML) models. Furthermore, patients from the SEER database were randomly divided into a training set and validation set at a ratio of 7 to 3 to develop the prognostic model which predicts survival of patients PSC with DM. Univariate and multivariate Cox regression analyses have also been performed in the training set to identify independent factors, and a prognostic nomogram for cancer-specific survival (CSS) for PSC patients with DM.
Results
For the diagnostic model for DM, 589 patients with PSC in the training set, 255 patients in the internal and 94 patients in the external test set were eventually enrolled. The extreme gradient boosting (XGB) algorithm performed best on the external test set with an area under the curve (AUC) of 0.821. For the prognostic model, 270 PSC patients with DM in the training and 117 patients in the test set were enrolled. The nomogram displayed precise accuracy with AUC of 0.803 for 3-month CSS and 0.869 for 6-month CSS in the test set.
Conclusion
The ML model accurately identified individuals at high risk for DM who needed more careful follow-up, including appropriate preventative therapeutic strategies. The prognostic nomogram accurately predicted CSS in PSC patients with DM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Southwest Hospital of Third Military Medical University, Chongqing, China.
- Department of Urinary Medicine Center, Southwest Hospital of Third Military Medical University, Chongqing, China.
- Department of Neurosurgery Department, Southwest Hospital of Third Military Medical University, Chongqing, China.
Förderung
- Science-Health Joint Medical Scientific Research Project of Chongqing
Zitieren
APA
Yi, X., Xu, W., Tang, G., Zhang, L., Wang, K., Luo, H., & Zhou, X. (2023). Individual risk and prognostic value prediction by machine learning for distant metastasis in pulmonary sarcomatoid carcinoma: a large cohort study based on the SEER database and the Chinese population. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1105224
Vancouver
Yi X, Xu W, Tang G, Zhang L, Wang K, Luo H, et al. Individual risk and prognostic value prediction by machine learning for distant metastasis in pulmonary sarcomatoid carcinoma: a large cohort study based on the SEER database and the Chinese population. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1105224
BibTeX
@article{Yi2023,
author = {Yi, Xinglin and Xu, Wenhao and Tang, Guihua and Zhang, Lingye and Wang, Kaishan and Luo, Hu and Zhou, Xiangdong},
title = {Individual risk and prognostic value prediction by machine learning for distant metastasis in pulmonary sarcomatoid carcinoma: a large cohort study based on the SEER database and the Chinese population},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1105224}
}
EUVIMED